{"id":"growth-hormones-somatropin-recombinant","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Fluid retention/edema"},{"rate":null,"effect":"Carpal tunnel syndrome"},{"rate":null,"effect":"Arthralgia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Somatropin mimics endogenous growth hormone by activating GH receptors on target tissues, promoting linear growth in children, increasing lean body mass, decreasing fat mass, and enhancing metabolic function. It stimulates insulin-like growth factor 1 (IGF-1) production, which mediates many of the anabolic and growth-promoting effects of growth hormone.","oneSentence":"Somatropin is a recombinant human growth hormone that binds to growth hormone receptors to stimulate growth, metabolism, and body composition changes.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:31:35.653Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Growth hormone deficiency in children"},{"name":"Growth hormone deficiency in adults"},{"name":"Short stature associated with Turner syndrome"},{"name":"Chronic kidney disease-related growth failure"},{"name":"Prader-Willi syndrome"}]},"trialDetails":[{"nctId":"NCT07481656","phase":"PHASE4","title":"Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH-ABI-RCT)","status":"NOT_YET_RECRUITING","sponsor":"Anhui Provincial Hospital","startDate":"2026-04-10","conditions":"Acute Brain Injuries, Moderate to Severe Traumatic Brain Injury","enrollment":160},{"nctId":"NCT07036003","phase":"PHASE1, PHASE2","title":"Recombinant Human Growth Hormone (rHGH) for Knee Osteoarthritis (KORR)","status":"RECRUITING","sponsor":"Dr. David Wasserstein","startDate":"2025-10-31","conditions":"Knee Osteoarthritis (Knee OA), Knee Osteoarthritis (OA)","enrollment":34},{"nctId":"NCT00663611","phase":"PHASE1","title":"Growth Hormone Administration and the Human Immune System","status":"COMPLETED","sponsor":"National Institute on Aging (NIA)","startDate":"2006-10-19","conditions":"Healthy Volunteers","enrollment":66},{"nctId":"NCT06927310","phase":"PHASE3","title":"The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short Stature","status":"RECRUITING","sponsor":"Xiamen Amoytop Biotech Co., Ltd.","startDate":"2025-04-28","conditions":"Idiopathic Short Stature","enrollment":300},{"nctId":"NCT07221851","phase":"PHASE3","title":"Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders","status":"RECRUITING","sponsor":"Ascendis Pharma A/S","startDate":"2025-12-12","conditions":"Turner Syndrome, Short Stature Homeobox Gene Mutation, Idiopathic Short Stature","enrollment":186},{"nctId":"NCT07450001","phase":"PHASE1, PHASE2","title":"A Study of GenSci134 in Children With Growth Hormone Deficiency (PGHD)","status":"NOT_YET_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2026-03-06","conditions":"Pediatric Growth Hormone Deficiency","enrollment":128},{"nctId":"NCT07450053","phase":"PHASE1, PHASE2","title":"A Study (Phase 1b/2) of GenSci134 in Children With Idiopathic Short Stature (ISS)","status":"NOT_YET_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2026-03-06","conditions":"Idiopathic Short Stature","enrollment":128},{"nctId":"NCT07309562","phase":"PHASE3","title":"The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born Small for Gestational Age","status":"RECRUITING","sponsor":"Xiamen Amoytop Biotech Co., Ltd.","startDate":"2026-01-20","conditions":"Small for Gestational Age","enrollment":141},{"nctId":"NCT06668805","phase":"PHASE2","title":"A Basket Study of Vosoritide in Children With Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment","status":"RECRUITING","sponsor":"BioMarin Pharmaceutical","startDate":"2024-11-22","conditions":"Short Stature Homeobox- Containing Gene SHOX Deficiency, Noonan Syndrome, Turner Syndrome","enrollment":54},{"nctId":"NCT07260500","phase":"PHASE2","title":"A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmacokinetics","status":"RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2025-11-11","conditions":"Short Stature Children Born Small for Gestational Age (SGA)","enrollment":72},{"nctId":"NCT07173036","phase":"NA","title":"Evaluation of (Cardio)Metabolic and Auxological Outcomes of GHD Patients Under rhGH or LAGH With Stratification According to IGF-1 Levels","status":"NOT_YET_RECRUITING","sponsor":"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","startDate":"2026-03-01","conditions":"Growth Hormone Deficiency","enrollment":300},{"nctId":"NCT06558422","phase":"PHASE1","title":"Human Models of Selective Insulin Resistance: Pancreatic Clamp","status":"NOT_YET_RECRUITING","sponsor":"Columbia University","startDate":"2027-01-01","conditions":"Insulin Resistance, Hyperinsulinemia, Metabolic Dysfunction Associated Steatotic Liver Disease","enrollment":36},{"nctId":"NCT05724134","phase":"PHASE1","title":"Pancreatic Clamp in NAFLD","status":"COMPLETED","sponsor":"Columbia University","startDate":"2023-08-29","conditions":"Insulin Resistance, Prediabetic State, Hyperinsulinemia","enrollment":18},{"nctId":"NCT05690386","phase":"PHASE2","title":"A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ascendis Pharma Endocrinology Division A/S","startDate":"2023-02-15","conditions":"Turner Syndrome","enrollment":48},{"nctId":"NCT05171855","phase":"PHASE3","title":"A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency","status":"COMPLETED","sponsor":"Ascendis Pharma Endocrinology Division A/S","startDate":"2021-12-16","conditions":"Adult Growth Hormone Deficiency, Endocrine System Diseases, Hormone Deficiency","enrollment":220},{"nctId":"NCT07323329","phase":"PHASE2, PHASE3","title":"Growth Hormone and Dehydroepiandrosterone Role in Vitro Fertilization","status":"RECRUITING","sponsor":"Beni-Suef University","startDate":"2025-10-10","conditions":"Infertility, Infertility (IVF Patients)","enrollment":165},{"nctId":"NCT04867317","phase":"PHASE3","title":"Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2025-01-13","conditions":"Adult Growth Hormone Deficiency, Mild Traumatic Brain Injury","enrollment":172},{"nctId":"NCT04020913","phase":"","title":"Skeletal Muscle Effects of GH in Boys","status":"COMPLETED","sponsor":"Nemours Children's Clinic","startDate":"2019-07-22","conditions":"Growth Hormone Deficiency, Idiopathic Short Stature","enrollment":45},{"nctId":"NCT05602766","phase":"","title":"Ngenla Subcutaneous Injection Special Investigation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2023-02-06","conditions":"Growth Hormone Deficiency Without Epiphyseal Closure","enrollment":1},{"nctId":"NCT03091374","phase":"PHASE2","title":"Impact of Recombinant Human Growth Hormone on HIV Persistence","status":"COMPLETED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2016-12","conditions":"Human Immunodeficiency Virus, Growth Hormone Treatment","enrollment":22},{"nctId":"NCT05308927","phase":"","title":"French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome","status":"ENROLLING_BY_INVITATION","sponsor":"Novo Nordisk A/S","startDate":"2022-03-16","conditions":"Noonan Syndrome","enrollment":221},{"nctId":"NCT05746650","phase":"NA","title":"Improving Tissue Repair After Injury in the Muscle-tendon Interface Muscle Tissue Injury","status":"RECRUITING","sponsor":"Bispebjerg Hospital","startDate":"2023-02-24","conditions":"Muscle Injury","enrollment":40},{"nctId":"NCT06037473","phase":"","title":"The Efficacy and Safety of PEGylated GH for the Treatment of Short Stature in Chinese Children-GLOBE Reg","status":"RECRUITING","sponsor":"Beijing Children's Hospital","startDate":"2023-08-01","conditions":"Growth Hormone Treatment, Growth Disorders","enrollment":2600},{"nctId":"NCT06294860","phase":"","title":"Biological Age in Children With GH Deficiency Undergoing Hormone Replacement Therapy","status":"COMPLETED","sponsor":"Istituto Auxologico Italiano","startDate":"2023-06-19","conditions":"Growth Hormone Deficiency, Short Stature","enrollment":10},{"nctId":"NCT05355272","phase":"PHASE2","title":"Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT)","status":"RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2024-03-11","conditions":"Gulf War Syndrome, Adult Growth Hormone Deficiency","enrollment":20},{"nctId":"NCT06797505","phase":"PHASE1","title":"A Bioequivalence Study of Two Different PEG-rhGH Preparations","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2025-02-10","conditions":"Pediatric Growth Hormone Deficiency (PGHD)","enrollment":87},{"nctId":"NCT02968004","phase":"PHASE3","title":"Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children","status":"COMPLETED","sponsor":"OPKO Health, Inc.","startDate":"2016-12","conditions":"Pediatric Growth Hormone Deficiency","enrollment":224},{"nctId":"NCT07016802","phase":"PHASE1","title":"A Clinical Study of GenSci134 in Healthy Male Adults","status":"RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2025-06-23","conditions":"Healthy Volunteers","enrollment":64},{"nctId":"NCT05382637","phase":"PHASE2","title":"Growth Hormone in a Patient With a Dominant-Negative GHR Mutation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's National Research Institute","startDate":"2022-08-26","conditions":"Growth Disorders","enrollment":1},{"nctId":"NCT06295341","phase":"","title":"Short Stature and Psychological Well-being","status":"COMPLETED","sponsor":"Istituto Auxologico Italiano","startDate":"2023-05-10","conditions":"Short Stature, Short; Stature, Psychosocial","enrollment":80},{"nctId":"NCT06135168","phase":"PHASE1","title":"A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2023-10-31","conditions":"Pediatric Growth Hormone Deficiency (PGHD)","enrollment":60},{"nctId":"NCT06135155","phase":"PHASE1","title":"A Clinical Trial to Compare Pharmacokinetics of Two Different PEG-rhGH Preparations","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2023-11-06","conditions":"Pediatric Growth Hormone Deficiency (PGHD)","enrollment":48},{"nctId":"NCT06385145","phase":"PHASE1","title":"A Bioavailability Study of Two Different PEG-rhGH Preparations.","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2024-05-08","conditions":"Pediatric Growth Hormone Deficiency (PGHD)","enrollment":16},{"nctId":"NCT06907121","phase":"PHASE2, PHASE3","title":"Investigation of Growth Hormone and Platelet-Rich Plasma on Joint Health","status":"NOT_YET_RECRUITING","sponsor":"Integrant Pty Ltd","startDate":"2025-06-01","conditions":"Arthritis Ankle, Arthritis Knee","enrollment":60},{"nctId":"NCT06900335","phase":"","title":"Functional Connectome in Prader-Willi Syndrome: Neuroimaging and AI to Assess Therapeutic Impact","status":"COMPLETED","sponsor":"Corporacion Parc Tauli","startDate":"2025-03-01","conditions":"Prader Willi Syndrome, Hyperphagia, Behavior Disorders","enrollment":101},{"nctId":"NCT06863363","phase":"PHASE4","title":"PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese Adults","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"","conditions":"Non-diabetic Obesity","enrollment":212},{"nctId":"NCT03554265","phase":"PHASE3","title":"Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2018-08-06","conditions":"Traumatic Brain Injury, Fatigue, Cognitive Impairment","enrollment":72},{"nctId":"NCT06840691","phase":"PHASE1","title":"A Bioequivalence Study of Two Different Processes of PEG-rhGH Preparations","status":"NOT_YET_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2025-05","conditions":"Pediatric Growth Hormone Deficiency (PGHD)","enrollment":87},{"nctId":"NCT04615273","phase":"PHASE3","title":"A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency","status":"COMPLETED","sponsor":"Ascendis Pharma Endocrinology Division A/S","startDate":"2020-12-03","conditions":"Growth Hormone Deficiency, Endocrine System Diseases, Hormone Deficiency","enrollment":264},{"nctId":"NCT06768411","phase":"NA","title":"The Dosage Exploration Study of PEG-rhGH for Treating Short Stature in Prepubertal and Pubertal Children","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital of Wenzhou Medical University","startDate":"2025-01-15","conditions":"Short Stature","enrollment":240},{"nctId":"NCT06722079","phase":"","title":"A Real-world Study of Long-acting Growth Hormone Injection for Turner Syndrome","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2022-11-08","conditions":"Turner Syndrome","enrollment":743},{"nctId":"NCT06331026","phase":"PHASE1","title":"A Bioequivalence Study of Two Different PEG-rhGH Preparations.","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2024-04-09","conditions":"Pediatric Growth Hormone Deficiency (PGHD)","enrollment":87},{"nctId":"NCT06110910","phase":"","title":"Long-term Efficacy and Safety Evaluation of Growth Hormone in Children in China(CGLS)","status":"RECRUITING","sponsor":"Xiaoping Luo","startDate":"2023-03-01","conditions":"Childhood Short Stature","enrollment":10000},{"nctId":"NCT06354023","phase":"PHASE2","title":"Human Growth Hormone Injections in the Knee Joint to Treat Osteoarthritis","status":"SUSPENDED","sponsor":"John Sledge","startDate":"2025-02-08","conditions":"Osteoarthritis, Knee","enrollment":23},{"nctId":"NCT06379659","phase":"PHASE1, PHASE2","title":"Effectiveness of Intrauterine Growth Hormone Administration as an add-on Therapy to Conventional Hormone Therapy Compared to Placebo in Patients With Thin Endometrium Undergoing Frozen Thawed Embryo Transfer","status":"COMPLETED","sponsor":"Isfahan University of Medical Sciences","startDate":"2024-05-01","conditions":"Thin Endometrium, Infertility Female, Infertility","enrollment":54},{"nctId":"NCT03288103","phase":"PHASE1, PHASE2","title":"Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2018-02-01","conditions":"Short Stature","enrollment":22},{"nctId":"NCT00684957","phase":"PHASE1, PHASE2","title":"Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors","status":"TERMINATED","sponsor":"Columbia University","startDate":"2008-01","conditions":"Growth Hormone Deficiency","enrollment":5},{"nctId":"NCT06126354","phase":"PHASE1","title":"Dexamethasone/Pancreatic Clamp P&F","status":"WITHDRAWN","sponsor":"Columbia University","startDate":"2024-07-01","conditions":"Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease","enrollment":""},{"nctId":"NCT06448195","phase":"PHASE4","title":"Effects of Growth Hormone Therapy on Metabolic Function in Fatty Liver Post-Pituitary Adenoma Surgery","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2023-01-01","conditions":"Growth Hormone Treatment","enrollment":40},{"nctId":"NCT03344458","phase":"PHASE3","title":"A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial","status":"COMPLETED","sponsor":"Ascendis Pharma A/S","startDate":"2017-12-19","conditions":"Growth Hormone Deficiency, Pediatric, Endocrine System Diseases, Hormone Deficiency","enrollment":298},{"nctId":"NCT04003207","phase":"PHASE2","title":"Growth Hormone Treatment in Children With Phelan McDermid Syndrome","status":"COMPLETED","sponsor":"Swathi Sethuram","startDate":"2019-09-13","conditions":"Phelan McDermid Syndrome","enrollment":6},{"nctId":"NCT04633057","phase":"PHASE3","title":"A Study to Evaluating the Efficacy and Safety of Recombinant Long-acting Human Growth Hormone (TJ101) in Children With Growth Hormone Deficiency","status":"COMPLETED","sponsor":"TJ Biopharma Co., Ltd.","startDate":"2021-01-25","conditions":"Pediatric Growth Hormone Deficiency","enrollment":168},{"nctId":"NCT00537914","phase":"PHASE4","title":"Safety and Efficacy of Omnitrope® (rhGH) in Short Children Born Small for Gestational Age (SGA)","status":"COMPLETED","sponsor":"Sandoz","startDate":"2008-02-06","conditions":"Small for Gestational Age","enrollment":278},{"nctId":"NCT01562834","phase":"PHASE4","title":"Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"1998-10-21","conditions":"Growth Hormone Disorder, Adult Growth Hormone Deficiency","enrollment":22},{"nctId":"NCT00163189","phase":"PHASE3","title":"Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm","status":"COMPLETED","sponsor":"Pfizer","startDate":"2005-01","conditions":"Growth Hormone Deficiency","enrollment":98},{"nctId":"NCT04513171","phase":"PHASE2, PHASE3","title":"Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency Children","status":"COMPLETED","sponsor":"Xiamen Amoytop Biotech Co., Ltd.","startDate":"2018-12-26","conditions":"Growth Hormone Deficiency","enrollment":434},{"nctId":"NCT05838885","phase":"PHASE2","title":"A Trial of YPEG-rhGH in Children With Short Stature","status":"COMPLETED","sponsor":"Xiamen Amoytop Biotech Co., Ltd.","startDate":"2022-02-15","conditions":"Idiopathic Short Stature, Small for Gestational Age, Turner Syndrome","enrollment":78},{"nctId":"NCT05809947","phase":"NA","title":"Mechanisms of Tissue Repair After Muscle Injury and Tendon Strain","status":"COMPLETED","sponsor":"Bispebjerg Hospital","startDate":"2023-04-11","conditions":"Muscle; Injury, Quadriceps (Thigh), Tendon Strain","enrollment":25},{"nctId":"NCT06103513","phase":"PHASE3","title":"Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children","status":"UNKNOWN","sponsor":"Northwell Health","startDate":"2023-12-10","conditions":"Growth Disorders, Growth Failure, Growth Hormone Treatment","enrollment":50},{"nctId":"NCT01306357","phase":"","title":"Evaluation of Overall Compliance and Duration of Zomacton® Treatment With the Zomajet® Needle-free Device","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2007-09","conditions":"Turner's Syndrome, Human Growth Hormone Deficiency","enrollment":87},{"nctId":"NCT00705172","phase":"","title":"Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2008-11","conditions":"Genetic Disorder, Prader-Willi Syndrome","enrollment":41},{"nctId":"NCT01897766","phase":"","title":"Special Investigation Of Genotropin Long Follow-Up For Patients With A Small For Gestational Age \"Scoped for Japanese\"","status":"COMPLETED","sponsor":"Pfizer","startDate":"2013-09-05","conditions":"Small for Gestational Age (SGA)","enrollment":482},{"nctId":"NCT06007417","phase":"PHASE3","title":"A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency","status":"UNKNOWN","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2023-12-01","conditions":"GHD","enrollment":162},{"nctId":"NCT06024967","phase":"PHASE3","title":"A Study to Investigate the Safety and Efficacy of Once-weekly PEG-somatropin (GenSci004) in Children With Growth Hormone Deficiency","status":"UNKNOWN","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2023-12-01","conditions":"GHD","enrollment":180},{"nctId":"NCT00742157","phase":"PHASE4","title":"Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)","status":"TERMINATED","sponsor":"University of Nebraska","startDate":"2003-09-01","conditions":"Short Bowel Syndrome","enrollment":5},{"nctId":"NCT03223025","phase":"PHASE3","title":"Comparing Efficacy and Safety of CinnaGen Biosimilar Growth Hormone (CinnaTropin®) Versus Nordilet in Children With Idiopathic Growth Hormone Deficiency","status":"COMPLETED","sponsor":"Cinnagen","startDate":"2016-03-09","conditions":"Idiopathic Growth Hormone Deficiency","enrollment":30},{"nctId":"NCT01529944","phase":"PHASE3","title":"Genetic Testing of Noonan Subjects Previously Treated With Norditropin®. An Extension to Trial GHNOO-1658","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2008-09","conditions":"Genetic Disorder, Noonan Syndrome","enrollment":22},{"nctId":"NCT00840944","phase":"PHASE4","title":"A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height","status":"UNKNOWN","sponsor":"Belgian Study Group for Pediatric Endocrinology","startDate":"2008-01","conditions":"Idiopathic Short Stature","enrollment":44},{"nctId":"NCT05900661","phase":"PHASE2, PHASE3","title":"The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-07-30","conditions":"Poor Responders","enrollment":300},{"nctId":"NCT00571727","phase":"PHASE2, PHASE3","title":"Long-Term Treatment With rhIGF-1 in GHIS","status":"COMPLETED","sponsor":"Ipsen","startDate":"1991-05-20","conditions":"Growth Hormone Insensitivity Syndrome","enrollment":92},{"nctId":"NCT00673309","phase":"PHASE2, PHASE3","title":"Assessment of Mechanisms of Improved Wound Healing","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2000-07","conditions":"Burns","enrollment":644},{"nctId":"NCT03123913","phase":"PHASE1","title":"Study of Testosterone and rHGH in FSHD","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2017-12-18","conditions":"Facioscapulohumeral Muscular Dystrophy","enrollment":20},{"nctId":"NCT05602090","phase":"PHASE2, PHASE3","title":"Growth Hormone For Poor Ovarian Reserve Patients in ICSI Trials","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2022-02-01","conditions":"Poor Ovarian Reserve","enrollment":120},{"nctId":"NCT05144035","phase":"PHASE4","title":"A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2022-04-06","conditions":"Small for Gestational Age Infant, Growth Hormone Treatment, Cognitive Developmental Disorder","enrollment":138},{"nctId":"NCT02719990","phase":"PHASE2","title":"Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD)","status":"TERMINATED","sponsor":"Versartis Inc.","startDate":"2016-02-11","conditions":"Adult Growth Hormone Deficiency (AGHD)","enrollment":36},{"nctId":"NCT00572156","phase":"PHASE2","title":"rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency","status":"TERMINATED","sponsor":"Ipsen","startDate":"2007-12","conditions":"Insulin-like Growth Factor-1 Deficiency","enrollment":106},{"nctId":"NCT05353192","phase":"PHASE4","title":"A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia","status":"UNKNOWN","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2022-09-23","conditions":"Achondroplasia","enrollment":38},{"nctId":"NCT03038594","phase":"PHASE2, PHASE3","title":"Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2015-11-01","conditions":"Burns, Growth Hormone Treatment","enrollment":13},{"nctId":"NCT04121780","phase":"PHASE2","title":"Growth Hormone Replacement Therapy for Retried Professional Football Players","status":"RECRUITING","sponsor":"Center for Neurological Studies","startDate":"2019-10-08","conditions":"TBI (Traumatic Brain Injury), Concussion, Brain, Sport Injury","enrollment":42},{"nctId":"NCT02339090","phase":"PHASE3","title":"Long-Acting Growth Hormone in Children Compared to Daily rhGH","status":"COMPLETED","sponsor":"Versartis Inc.","startDate":"2015-08-26","conditions":"Growth Disorders","enrollment":138},{"nctId":"NCT02217345","phase":"PHASE2","title":"Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2017-06-02","conditions":"Nonalcoholic Fatty Liver Disease (NAFLD)","enrollment":131},{"nctId":"NCT03435627","phase":"","title":"Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome)","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2018-02-26","conditions":"Genetic Disorder, Noonan Syndrome","enrollment":71},{"nctId":"NCT01578135","phase":"","title":"French National Registry of Children Born Small for Gestational Age Treated With Somatropin","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2007-03-18","conditions":"Growth Disorder, Small for Gestational Age","enrollment":291},{"nctId":"NCT05105685","phase":"PHASE1, PHASE2","title":"Effectiveness of Recombinant Human Growth Hormone Therapy for Children With PMS","status":"COMPLETED","sponsor":"Affiliated Hospital of Jiangnan University","startDate":"2020-06-14","conditions":"Phelan-McDermid Syndrome, Growth Hormone Treatment","enrollment":6},{"nctId":"NCT02726542","phase":"EARLY_PHASE1","title":"Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2017-05-03","conditions":"NAFLD","enrollment":24},{"nctId":"NCT02973061","phase":"","title":"The Impact of the Use of Recombinant Human Growth Hormone on ADHD Characteristics in Children and Adolescents","status":"UNKNOWN","sponsor":"Assaf-Harofeh Medical Center","startDate":"2015-01","conditions":"Growth Hormone Deficiency, Attention Deficit Disorder, Idiopathic Short Stature","enrollment":100},{"nctId":"NCT05281341","phase":"PHASE4","title":"Effect of GH Administration in Poor Responders Undergoing Intracytoplasmic Sperm Injection (ICSI)","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2020-01-13","conditions":"Female Infertility","enrollment":160},{"nctId":"NCT02526420","phase":"PHASE2","title":"Versartis International Trial in Adults With Long-Acting Growth Hormone","status":"COMPLETED","sponsor":"Versartis Inc.","startDate":"2015-07","conditions":"Adult Growth Hormone Deficiency","enrollment":36},{"nctId":"NCT02413138","phase":"PHASE2, PHASE3","title":"Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317)","status":"TERMINATED","sponsor":"Versartis Inc.","startDate":"2015-08-08","conditions":"Pediatric Growth Hormone Deficiency, Growth Disorders","enrollment":41},{"nctId":"NCT01614171","phase":"NA","title":"Growth Hormone for Osteoporosis Pseudoglioma Syndrome","status":"WITHDRAWN","sponsor":"University of Maryland, Baltimore","startDate":"2013-12","conditions":"Osteoporosis Pseudoglioma Syndrome","enrollment":""},{"nctId":"NCT02597660","phase":"PHASE2","title":"A Study to Evaluate the Efficacy of Somatropin in the Treatment of Patellar Tendinopathy","status":"WITHDRAWN","sponsor":"Hospital for Special Surgery, New York","startDate":"2020-05-01","conditions":"Tendinopathy","enrollment":""},{"nctId":"NCT02205450","phase":"","title":"Growth Hormone in Children Under 2 Years With Prader-Willi in Hospital of Sabadell","status":"COMPLETED","sponsor":"Corporacion Parc Tauli","startDate":"2014-09","conditions":"Prader-Willi Syndrome","enrollment":16},{"nctId":"NCT02410343","phase":"PHASE3","title":"Study of TV-1106 in Growth Hormone-Deficient Adults","status":"TERMINATED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2015-04-30","conditions":"Growth Hormone Deficiency","enrollment":14},{"nctId":"NCT03305016","phase":"PHASE3","title":"A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency","status":"COMPLETED","sponsor":"Ascendis Pharma Endocrinology Division A/S","startDate":"2017-11-13","conditions":"Growth Hormone Deficiency, Pediatric, Endocrine System Diseases, Hormone Deficiency","enrollment":146},{"nctId":"NCT02781727","phase":"PHASE3","title":"A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)","status":"COMPLETED","sponsor":"Ascendis Pharma Endocrinology Division A/S","startDate":"2016-12-13","conditions":"Growth Hormone Deficiency, Pediatric, hGH (Human Growth Hormone), Endocrine System Diseases","enrollment":162},{"nctId":"NCT01811576","phase":"PHASE2","title":"Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone Deficiency","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2013-03-31","conditions":"Growth Hormone Deficiency","enrollment":52},{"nctId":"NCT02410356","phase":"PHASE3","title":"Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)","status":"TERMINATED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2015-04-30","conditions":"Growth Hormone Deficiency","enrollment":34},{"nctId":"NCT02092077","phase":"PHASE2","title":"A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children","status":"TERMINATED","sponsor":"Teva Pharmaceutical Industries, Ltd.","startDate":"2014-04-30","conditions":"Growth Hormone-Deficiency","enrollment":65},{"nctId":"NCT01169103","phase":"PHASE2","title":"Effect of Recombinant Human Growth Hormone (rhGH) on Abdominal Fat and Cardiovascular Risk in Obese Girls","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2010-03","conditions":"Obesity","enrollment":22},{"nctId":"NCT00006143","phase":"NA","title":"Growth Hormone Treatment of Children With HIV-Associated Growth Failure","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":102}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Cetrorelix"],"phase":"marketed","status":"active","brandName":"Growth Hormones Somatropin Recombinant","genericName":"Growth Hormones Somatropin Recombinant","companyName":"ClinAmygate","companyId":"clinamygate","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Somatropin is a recombinant human growth hormone that binds to growth hormone receptors to stimulate growth, metabolism, and body composition changes. Used for Growth hormone deficiency in children, Growth hormone deficiency in adults, Short stature associated with Turner syndrome.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}